Search Results - "Zajusz, A"

1019 poster HIGH-RISK PROSTATE CANCER PATIENTS WITH INITIAL PSA100 NG/ML TREATED WITH EXTERNAL-BEAM RADIOTHERAPY by Smolska-Ciszewska, B, Plewicki, G, Giglok, M, Behrendt, K, Gawkowska-Suwinska, M, Nowicka, E, Dworzecki, T, Dworzecka, U, Zajusz, A

Get full text

719 poster LONG-TERM RESULTS OF HIGH-DOSE EBRT AND EBRT WITH BRACHYTHERAPY BOOST IN TREATMENT OF PROSTATE CANCER PATIENTS by Smolska-Ciszewska, B, Miszczyk, L, Bialas, B, Gawkowska-Suwinska, M, Plewicki, G, Fijalkowski, M, Giglok, M, Behrendt, K, Nowicka, E, Zajusz, A

Get full text

725 poster SALVAGE HDR BRACHYTERAPHY FOR LOCAL RECCURANCES OF PROSTATE CANCER PRELIMINARY RESULTS by Gawkowska-Suwinska, M, Fijalkowski, M, Bialas, B, Kellas-Sleczka, S, Szlag, M, Bystrzycka, J, Andrejczuk, A, Zajusz, A, Smolska-Ciszewska, B, Plewicki, G, Behrendt, K, Nowicka, E, Giglok, M, Olejnik, K

Get full text

124 poster: Comparison of EBRT With Combined Treatment (EBRT With HDR Brachytherapy) for Prostate Cancer Patients by Smolska, B, Leszek, M, Bialas, B, Gawkowska-Suwinska, M, Kellas-Ślęczka, S, Plewicki, G, Fijalkowski, M, Giglok, M, Behrendt, K, Nowicka, E, Zajusz, A

Get full text

1915PPrognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in male breast cancer patients by Huszno, J, Kolosza, Z, Mrochem-Kwarciak, J, Zajusz, A

“…Abstract Background Inflammation impacts each step of tumorigenesis, including tumor initiation, promotion and metastatic progression. Biomarkers including the…”
Get full text

Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in male breast cancer patients by Huszno, J., Kolosza, Z., Mrochem-Kwarciak, J., Zajusz, A.

Get full text

1915P - Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in male breast cancer patients by Huszno, J., Kolosza, Z., Mrochem-Kwarciak, J., Zajusz, A.

“…Inflammation impacts each step of tumorigenesis, including tumor initiation, promotion and metastatic progression. Biomarkers including the neutrophil,…”
Get full text

Hyperfractionated or Accelerated Radiotherapy in Lung Cancer: An Individual Patient Data Meta-Analysis by MAUGUEN, Audrey, LE PECHOUX, Cécile, ZAJUSZ, Aleksander, DAHLBERG, Suzanne E, NANKIVELL, Matthew, MANDREKAR, Sumithra J, PAULUS, Rebecca, BEHRENDT, Katarzyna, KOCH, Rainer, BISHOP, James F, DISCHE, Stanley, ARRIAGADA, Rodrigo, SAUNDERS, Michele I, RUYSSCHER, Dirk De, PIGNON, Jean-Pierre, SCHILD, Steven E, TURRISI, Andrew T, BAUMANN, Michael, SAUSE, William T, BALL, David, BELANI, Chandra P, BONNER, James A

“…In lung cancer, randomized trials assessing hyperfractionated or accelerated radiotherapy seem to yield conflicting results regarding the effects on overall…”
Get full text

Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer by Maciejewski, B, Zajusz, A, Pilecki, B, Swiatnicka, J, Skladowski, K, Dorr, W, Kummermehr, J, Trott, K R

“…In 16 patients treated for squamous cell carcinoma of the oral cavity or oropharynx with an accelerated split course regimen, acute mucosal reactions were…”
Get more information

Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study by Lueza, Béranger, Mauguen, Audrey, Pignon, Jean-Pierre, Rivero-Arias, Oliver, Bonastre, Julia

“…In economic evaluation, a commonly used outcome measure for the treatment effect is the between-arm difference in restricted mean survival time (rmstD). This…”
Get full text

Clinical results of radiotherapy for the oropharyngeal cancer by Zajusz, A

Get more information

Normobaric oxygen as a sensitizer in radiotherapy for advanced head and neck cancer by ZAJUSZ, A, MACIEJEWSKI, B, HLINIAK, A

“…The aim of this study was to evaluate radiosensitizing effect of normobaric oxygen breathing in radiotherapy for advanced head and neck cancers. Forty seven…”
Get full text

N28 HDR INTERSTITIAL BRACHYTHERAPY AS THE ORGAN PRESERVATION TREATMENT OF PENILE NEOPLASM by Giglok, M, Bialas, B, Fijalkowski, M, Smolska-Ciszewska, B, Kellas-Slęczka, S, Zajusz, A, Gawkowska-Suwińska, M

Get full text

Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patients by Ramaekers, Bram L T, Joore, Manuela A, Lueza, Béranger, Bonastre, Julia, Mauguen, Audrey, Pignon, Jean-Pierre, Le Pechoux, Cecile, De Ruysscher, Dirk K M, Grutters, Janneke P C

“…Modified fractionation radiotherapy (RT), delivering multiple fractions per day or shortening the overall treatment time, improves overall survival for non…”
Get more information

ROC analysis of benefit and limitation in radiotherapy for cancer of the oral cavity by MACIEJEWSKI, B, ZAJUSZ, A, ROTA, L

“…The ROC analysis of optimalization of radiation treatment of cancer of the oral cavity was carried out. Material of 210 patients with squamous cell carcinoma…”
Get full text

Importance of tumor size and repopulation for radiocurability of skin cancer by Maciejewski, B A, Skates, S, Zajusz, A, Lange, D

“…Data on 946 skin cancers treated by radiation were used to estimate the importance of repopulation. Six different treatment regimes were used from a single…”
Get full text

Radiobiological predictors of tumor and acute normal tissue response in radiotherapy for head and neck cancers by MACIEJEWSKI, B, SKLADOWSKI, K, ZAJUSZ, A

“…Importance of two assay of the measurements of potential doubling time (Tpot.) and survival fraction at 2.0 Gy (SF2) and a method modifying acute radiation…”
Get full text

Sequential combination of radio-chemotherapy (5-fluorouracil, cis-platinum and irradiation) in the management of locally advanced head and neck cancers by Suwiński, R, Pilecki, B, Składowski, K, Swiatnicka, J, Zajusz, A, Przeorek, W, Utracka-Hutka, B, Jakus, G, Lange, B, Lange, D, Tarnawski, R, Maciejewski, B

“…Thirty-seven previously untreated patients with advanced, inoperable head and neck were treated with a sequential courses combining hypofractionated…”
Get full text

P115 - Overall and progression free survival time in mRCC patients – Clinicopathological risk group analysis by Huszno, J., Kotosza, Z., Zajusz, A.

Get full text

Overall and progression free survival time in mRCC patients – Clinicopathological risk group analysis by Huszno, J., Kotosza, Z., Zajusz, A.

Get full text